Copyright: ©Author(s) 2026.
World J Hepatol. Mar 27, 2026; 18(3): 114519
Published online Mar 27, 2026. doi: 10.4254/wjh.v18.i3.114519
Published online Mar 27, 2026. doi: 10.4254/wjh.v18.i3.114519
Table 4 Multivariable logistic regression: Independent risk factors for mortality in patients hospitalised with respiratory syncytial virus
| Variable | Adjusted OR | 95% confidence interval | P value |
| Age (years) | 1.05 | 1.02-1.09 | 0.002 |
| Sex (female) | 1.01 | 0.48-2.16 | 0.980 |
| Cirrhosis | 8.56 | 0.3-245.53 | 0.154 |
| Ischaemic heart disease | 1.72 | 0.38-7.32 | 0.460 |
| Congestive heart failure | 0.9 | 0.3-2.63 | 0.853 |
| COPD | 0.72 | 0.2-2.29 | 0.588 |
| Chronic kidney disease | 2.02 | 0.63-6.44 | 0.229 |
| Diabetes | 2.19 | 1.01-4.84 | 0.049 |
- Citation: Walia N, Lu I, Hannah N, Sood S. Evaluating cirrhosis and respiratory syncytial virus infection: Should we vaccinate? World J Hepatol 2026; 18(3): 114519
- URL: https://www.wjgnet.com/1948-5182/full/v18/i3/114519.htm
- DOI: https://dx.doi.org/10.4254/wjh.v18.i3.114519